Loading...

New formaldehyde exposure limits

Starting July 12, 2024 the healthcare sector must comply with the new, stricter occupational exposure limits for formaldehyde, marking the end of the 5-year transitional period established by EU Directive 2019/983.

๐Ÿšจ ๐—ก๐—ฒ๐˜„ ๐—ข๐—ฐ๐—ฐ๐˜‚๐—ฝ๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—˜๐˜…๐—ฝ๐—ผ๐˜€๐˜‚๐—ฟ๐—ฒ ๐—Ÿ๐—ถ๐—บ๐—ถ๐˜๐˜€ ๐—ณ๐—ผ๐—ฟ ๐—™๐—ผ๐—ฟ๐—บ๐—ฎ๐—น๐—ฑ๐—ฒ๐—ต๐˜†๐—ฑ๐—ฒ: ๐Ÿฌ.๐Ÿฏ๐Ÿณ ๐—บ๐—ด/๐—บยณ (๐Ÿฌ.๐Ÿฏ ๐—ฝ๐—ฝ๐—บ)

These new limits underscore the commitment to reducing formaldehyde exposure, significantly impacting medical procedures and tissue preservation methods. In this evolving regulatory landscape, finding alternatives to formalin is crucial.

Non-compliance with these new limits can lead to severe consequences. Failing to adhere to the new limits would expose workers to health and safety risks, increasing the likelihood of litigation. Healthcare institutions may face legal actions, financial penalties, and criminal charges. This could also cause significant reputational damage to the involved institutions.

Exploring safer substitutes for formaldehyde is essential to protect health and comply with regulations. It is now imperative to consider alternatives immediately.

Our GAFยฎ, the innovative formalin-free fixative, offers a non-toxic and environmentally sustainable solution. GAFยฎ improves diagnostic accuracy while ensuring worker safety. GAFยฎ is safe and ๐—ฐ๐—ผ๐—บ๐—ฝ๐—น๐—ถ๐—ฎ๐—ป๐˜ ๐˜„๐—ถ๐˜๐—ต ๐—ฟ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€.

๐—ก๐—ผ๐—ป-๐—ฐ๐—ฎ๐—ฟ๐—ฐ๐—ถ๐—ป๐—ผ๐—ด๐—ฒ๐—ป๐—ถ๐—ฐ: ๐˜‚๐—ป๐—น๐—ถ๐—ธ๐—ฒ ๐—™๐—ผ๐—ฟ๐—บ๐—ฎ๐—น๐—ถ๐—ป, ๐—š๐—”๐—™ยฎ ๐—ผ๐—ณ๐—ณ๐—ฒ๐—ฟ๐˜€ ๐—ฎ ๐˜€๐—ฎ๐—ณ๐—ฒ๐—ฟ ๐—ฎ๐—น๐˜๐—ฒ๐—ฟ๐—ป๐—ฎ๐˜๐—ถ๐˜ƒ๐—ฒ ๐˜„๐—ถ๐˜๐—ต๐—ผ๐˜‚๐˜ ๐—ฐ๐—ผ๐—บ๐—ฝ๐—ฟ๐—ผ๐—บ๐—ถ๐˜€๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐—พ๐˜‚๐—ฎ๐—น๐—ถ๐˜๐˜† ๐—ผ๐—ณ ๐—ฟ๐—ฒ๐˜€๐˜‚๐—น๐˜๐˜€.

Join us towards a formalin free hospital